Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)

Name: Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)
License: Public Domain

Atara Biotherapeutics

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

nasopharyngeal-carcinoma

nasopharyngeal carcinoma, nasopharyngeal neoplasms, epstein-barr virus infections, epstein-barr viraemia, epstein-barr virus-associated nasopharyngeal carcinoma (ebv+ npc)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 674906
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.